DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer|HER2-negative Breast Cancer
Interventions: BIOLOGICAL: HER2 - primed Dendritic cells|BIOLOGICAL: HER3 - primed Dendritic cells
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Collaborators: The Shulas' Foundation